Roivant Sciences Ltd. - Net Worth and Insider Trading

Roivant Sciences Ltd. Net Worth

The estimated net worth of Roivant Sciences Ltd. is at least $3.7 Billion dollars as of 2024-06-18. Roivant Sciences Ltd. is the Director, 10% Owner of Immunovant Inc and owns about 79,805,331 shares of Immunovant Inc (IMVT) stock worth over $2.1 Billion. Roivant Sciences Ltd. is the 10% Owner of Myovant Sciences Ltd and owns about 45,008,604 shares of Myovant Sciences Ltd (MYOV) stock worth over $1.2 Billion. Roivant Sciences Ltd. is also the 10% Owner of Urovant Sciences Ltd and owns about 22,860,013 shares of Urovant Sciences Ltd (UROV) stock worth over $371 Million. Besides these, Roivant Sciences Ltd. also holds Sio Gene Therapies Inc (SIOX) . Details can be seen in Roivant Sciences Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Roivant Sciences Ltd. has not made any transactions after 2023-10-02 and currently still holds the listed stock(s).

Transaction Summary of Roivant Sciences Ltd.

To

Roivant Sciences Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Roivant Sciences Ltd. owns 6 companies in total, including Immunovant Inc (IMVTU) , Sio Gene Therapies Inc (SIOX) , and Myovant Sciences Ltd (MYOV) among others .

Click here to see the complete history of Roivant Sciences Ltd.’s form 4 insider trades.

Insider Ownership Summary of Roivant Sciences Ltd.

Ticker Comapny Transaction Date Type of Owner
IMVTU Immunovant Inc 2020-09-17 10 percent owner
SIOX Sio Gene Therapies Inc 2020-02-24 10 percent owner
MYOV Myovant Sciences Ltd 2019-12-17 10 percent owner
LIMIT LIMIT 2019-12-27 10 percent owner
LIMIT LIMIT 2021-10-18 10 percent owner
LIMIT LIMIT 2023-10-02 10 percent owner

Roivant Sciences Ltd. Latest Holdings Summary

Roivant Sciences Ltd. currently owns a total of 4 stocks. Among these stocks, Roivant Sciences Ltd. owns 79,805,331 shares of Immunovant Inc (IMVT) as of October 2, 2023, with a value of $2.1 Billion and a weighting of 56.73%. Roivant Sciences Ltd. owns 45,008,604 shares of Myovant Sciences Ltd (MYOV) as of December 17, 2019, with a value of $1.2 Billion and a weighting of 32.96%. Roivant Sciences Ltd. also owns 22,860,013 shares of Urovant Sciences Ltd (UROV) as of June 19, 2019, with a value of $371 Million and a weighting of 10.08%. The other 1 stocks Sio Gene Therapies Inc (SIOX) have a combined weighting of 0.24% among all his current holdings.

Latest Holdings of Roivant Sciences Ltd.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IMVT Immunovant Inc 2023-10-02 79,805,331 26.19 2,090,101,619
MYOV Myovant Sciences Ltd 2019-12-17 45,008,604 26.98 1,214,332,136
UROV Urovant Sciences Ltd 2019-06-19 22,860,013 16.24 371,246,611
SIOX Sio Gene Therapies Inc 2020-02-24 18,577,380 0.48 8,879,988

Holding Weightings of Roivant Sciences Ltd.


Roivant Sciences Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, Roivant Sciences Ltd. has made a total of 4 transactions in Immunovant Inc (IMVT) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Immunovant Inc is the acquisition of 1,526,316 shares on October 2, 2023, which cost Roivant Sciences Ltd. around $58 Million.

According to the SEC Form 4 filings, Roivant Sciences Ltd. has made a total of 4 transactions in Myovant Sciences Ltd (MYOV) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Myovant Sciences Ltd is the acquisition of 245,000 shares on December 17, 2019, which cost Roivant Sciences Ltd. around $4 Million.

According to the SEC Form 4 filings, Roivant Sciences Ltd. has made a total of 0 transactions in Urovant Sciences Ltd (UROV) over the past 5 years. The most-recent trade in Urovant Sciences Ltd is the acquisition of 18,204 shares on June 19, 2019, which cost Roivant Sciences Ltd. around $151,457.

More details on Roivant Sciences Ltd.'s insider transactions can be found in the Insider Trading History of Roivant Sciences Ltd. table.

Insider Trading History of Roivant Sciences Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Roivant Sciences Ltd. Trading Performance

GuruFocus tracks the stock performance after each of Roivant Sciences Ltd.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Roivant Sciences Ltd. is 4.81%. GuruFocus also compares Roivant Sciences Ltd.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Roivant Sciences Ltd. within 3 months outperforms 13 times out of 23 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Roivant Sciences Ltd.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Roivant Sciences Ltd.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
15 out of 22 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 0.68 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -1.07 LIMIT LIMIT LIMIT LIMIT LIMIT

Roivant Sciences Ltd. Ownership Network

Ownership Network List of Roivant Sciences Ltd.

No Data

Ownership Network Relation of Roivant Sciences Ltd.

Insider Network Chart

Roivant Sciences Ltd. Owned Company Details

What does Immunovant Inc do?

Who are the key executives at Immunovant Inc?

Roivant Sciences Ltd. is the 10 percent owner of Immunovant Inc. Other key executives at Immunovant Inc include Chief Dev. & Tech. Officer Julia G. Butchko , Chief Scientific Officer Michael James Elliott , and director & Chief Executive Officer Peter Salzmann .

Immunovant Inc (IMVTU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Immunovant Inc (IMVTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunovant Inc (IMVTU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Immunovant Inc (IMVTU)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Immunovant Inc Insider Transactions

No Available Data

Roivant Sciences Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Roivant Sciences Ltd.. You might contact Roivant Sciences Ltd. via mailing address: Clarendon House, 2 Church Street, Hamilton D0 Hm11.

Discussions on Roivant Sciences Ltd.

No discussions yet.